Evaluation of RNAi therapeutics VIR-2218 and ALN-HBV for chronic hepatitis B: Results from randomized clinical trials

Ed Gane, Young‐Suk Lim, Jae Bum Kim, Vasant Jadhav, Ling Shen, Anna I. Bakardjiev, Stephen A. Huang, Andrea L. Cathcart, Florian A. Lempp, Maja M. Janas, Daniel Cloutier, Charalambos Kaittanis, Laura Sepp‐Lorenzino, Gregory Hinkle, Jörg Täubel, Patrick Haslett, Stuart Milstein, Yesseinia Angleró-Rodríguez, Christy M. Hebner, Phillip S. Pang, Man‐Fung Yuen